Results 11 to 20 of about 235,603 (337)

Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in the Netherlands.

open access: yesPLoS Medicine, 2020
BackgroundBased on different genetic and environmental risk factors and histology, it has been proposed that rheumatoid arthritis (RA) consists of 2 types: autoantibody-positive and autoantibody-negative RA. However, until now, this remained hypothetical.
Xanthe M E Matthijssen   +3 more
doaj   +2 more sources

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing

open access: yesJAMA Neurology, 2021
Key Points Question What is the positive predictive value of myelin oligodendrocyte glycoprotein (MOG)–IgG1 testing in a clinical setting? Findings Of 1260 consecutive patients tested for MOG-IgG1 at the Mayo Clinic over 2 years, 92 (7.3%) were positive,
E. Sechi   +13 more
semanticscholar   +1 more source

Autoantibody-Specific Signalling in Pemphigus

open access: yesFrontiers in Medicine, 2021
Pemphigus is a severe autoimmune disease impairing barrier functions of epidermis and mucosa. Autoantibodies primarily target the desmosomal adhesion molecules desmoglein (Dsg) 1 and Dsg 3 and induce loss of desmosomal adhesion.
T. Schmitt, J. Waschke
semanticscholar   +1 more source

Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

open access: yesFrontiers in Immunology, 2020
Myasthenia gravis (MG) is an autoimmune disease characterized by muscle weakness and fatiguability of skeletal muscles. It is an antibody-mediated disease, caused by autoantibodies targeting neuromuscular junction proteins.
K. Lazaridis, S. Tzartos
semanticscholar   +1 more source

The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity

open access: yesRheumatology, 2020
Objectives In order to address the reliability of commercial assays to identify myositis-specific and -associated autoantibodies, we aimed to compare the results of two commercial immunoassays with the results obtained by protein immunoprecipitation ...
S. Tansley   +3 more
semanticscholar   +1 more source

Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management

open access: yesFrontiers in Neurology, 2020
Myasthenia gravis (MG) is the most common autoimmune disorder affecting the neuromuscular junction, characterized by skeletal muscle weakness and fatigability.
K. Lazaridis, S. Tzartos
semanticscholar   +1 more source

Comparison of clinical and laboratory characteristics in children with type 1 diabetes according to pancreatic autoantibodies [PDF]

open access: yesKorean Journal of Pediatrics, 2010
Purpose:The purpose of this study was to determine whether there is any difference in the clinical and laboratory characteristics of patients with autoantibody-positive and patients with autoantibody-negative type 1 diabetes at initial presentation ...
Ji Hae Choi   +4 more
doaj   +1 more source

Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment

open access: yesFrontiers in Immunology, 2022
BackgroundChronic immune stimulation by hepatitis C virus (HCV) may cause occurrence of several autoantibodies in infected patients, with or without features of clinically overt autoimmune diseases.
Ciro Romano   +6 more
doaj   +1 more source

Screening for type 1 diabetes-, thyroid-, gastric-, and adrenal-specific humoral autoimmunity in 529 children and adolescents with celiac disease at diagnosis identifies as positive one in every nine patients [PDF]

open access: yes, 2016
No abstract ...
Anania, Caterina   +9 more
core   +1 more source

Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study

open access: yesDiabetes Care, 2020
OBJECTIVE The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabetes (T1D). Here, we assessed the risk of autoantibody spreading to the second-appearing autoantibody and further progression to clinical disease in The ...
Kendra Vehik   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy